Does gabapentin affect heart rate?

Does Gabapentin Affect Heart Rate?

Gabapentin can affect heart rate, typically causing bradycardia (slowing of heart rate), particularly at higher doses or when combined with other cardiovascular medications. This effect appears to be mediated through both central nervous system mechanisms and peripheral sympathetic nervous system modulation.

Mechanism and Clinical Evidence

Gabapentin's cardiovascular effects occur through its binding to voltage-gated calcium channels at the α2δ subunit, which influences both cardiac function and autonomic nervous system regulation 1, 2. The drug reduces sympathetic nerve transmission and modulates cardiovascular control centers in the brainstem, specifically the nucleus tractus solitarii 2.

Direct Effects on Heart Rate

In clinical studies, gabapentin consistently demonstrates heart rate reduction:

• Preoperative gabapentin 800 mg significantly decreased heart rate during intubation compared to placebo and lower doses 3
• Meta-analysis showed gabapentin reduced heart rate by 8 beats per minute (95% CI: -11 to -5) one minute after intubation 4
• In hypertensive rats, acute gabapentin administration lowered both blood pressure and heart rate more than in normotensive controls 1

Autonomic Effects

Gabapentin modulates cardiac autonomic function through multiple pathways:

• Reduces plasma norepinephrine levels 1
• Abolishes nitroprusside-induced reflex tachycardia, indicating baroreceptor modulation 1
• May improve heart rate variability (HRV) in diabetic neuropathy patients, with one small trial showing an 11 ms increase in SDNN (standard deviation of normal-normal beats), though this was marginally significant 5

Clinical Considerations and Safety

Common Cardiovascular Side Effects

The FDA drug label does not list cardiac effects as primary adverse reactions 6. However, the most common side effects that may indirectly affect cardiovascular status include:

• Dizziness (17-28% in clinical trials)
• Somnolence (19-21%)
• Peripheral edema (8% in postherpetic neuralgia trials)

Critical Drug Interactions

Gabapentin significantly potentiates the cardiovascular effects of other cardiac medications:

• When combined with verapamil (calcium channel blocker), gabapentin enhanced negative chronotropic effects, causing greater reductions in heart rate and blood pressure 7
• Combined with metoprolol (beta-blocker), gabapentin further exacerbated bradycardia and hypotension beyond either drug alone 7
• These interactions are particularly concerning in patients with pre-existing cardiovascular disease 7

High-Risk Populations

Exercise particular caution in:

• Patients taking calcium channel blockers or beta-blockers concurrently
• Elderly patients (>65 years), who may have baseline bradycardia or conduction abnormalities
• Patients with pre-existing cardiovascular disease, where gabapentin's sympatholytic effects may be more pronounced 1
• Those with heart failure risk factors—though pregabalin (a related gabapentinoid) shows increased heart failure risk compared to gabapentin 8

Practical Management Approach

When prescribing gabapentin:

1. Baseline assessment: Check resting heart rate and blood pressure, particularly in patients >40 years or those with cardiovascular risk factors
2. Medication review: Identify concurrent use of calcium channel blockers, beta-blockers, or other rate-controlling agents
3. Dose titration: Start with lower doses (100-300 mg at bedtime) and titrate gradually over 1-7 days as tolerated 9
4. Monitoring: Reassess heart rate and blood pressure after dose increases, especially when reaching therapeutic doses (900-1800 mg/day for neuropathic pain)
5. Drug interactions: If combining with cardiovascular medications, consider more frequent monitoring and potentially lower doses of both agents 7

Important Caveats

While gabapentin affects heart rate through documented mechanisms, these effects are generally not severe enough to contraindicate its use in most patients. The FDA-approved prescribing information does not list cardiac arrhythmias or significant bradycardia as major adverse events in large clinical trials 6. However, the absence of systematic cardiac monitoring in most gabapentin trials means subtle effects may be underreported.

The clinical significance increases substantially when gabapentin is combined with other cardiovascular medications, where additive effects on heart rate and blood pressure become more pronounced and potentially problematic 7.